The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample.
Increase of myeloid microvesicles in the cerebrospinal fluid as biomarkers of microglia/microphage activation in neurological disorders / M. Matteoli, C. Verderio, R. Furlan.
Increase of myeloid microvesicles in the cerebrospinal fluid as biomarkers of microglia/microphage activation in neurological disorders
M. Matteoli;
2011
Abstract
The present invention relates to a method for the diagnosis and/or prognosis of a neurological disease characterized by an inflammatory process as well as a method for predicting and /or monitoring the efficacy of a treatment for a neurological pathology. The methods are based on the measurement of the amount of myeloid derived microvesicles in a cerebrospinal fluid sample.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
